Acasă › Cancer pulmonar › Kentucky › Lexington
Studii clinice pentru Cancer pulmonar în Lexington, KY
18 studii pentru Cancer pulmonar caută participanți în și în jurul orașului Lexington (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
În curs de recrutareFaza 3
- Baptist Health Lexington, Lexington
- Baptist Health Hamburg, Lexington
- University of Kentucky/Markey Cancer Center, Lexington
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
În curs de recrutareFaza 2
- University of Kentucky Chandler Medical Center ( Site 0019), Lexington
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- CommonSpirit Saint Joseph Hospital - Lexington, Lexington
- Saint Joseph Radiation Oncology Resource Center, Lexington
- CommonSpirit Saint Joseph Medical Center - East Lexington, Lexington
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
În curs de recrutareFaza 3
- University of Kentucky/Markey Cancer Center, Lexington
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
În curs de recrutareFaza 2/3
- Baptist Health Lexington, Lexington
- University of Kentucky Chandler Medical Center, Lexington
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
În curs de recrutareFaza 2/3
- Baptist Health Lexington, Lexington
- University of Kentucky Chandler Medical Center (UKCMC) - Markey Cancer Center (Lucille P. Markey Cancer Center), Lexington
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
În curs de recrutareFaza 1/2
- University of Kentucky/Markey Cancer Center, Lexington
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
În curs de recrutareFaza 3
- CHI Saint Joseph Cancer Center - East, Lexington
- University of Kentucky Chandler Medical Center, Lexington
A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)
În curs de recrutareFaza 2
- University of Kentucky ( Site 0019), Lexington
EXoPERT EMERALD Clinical Study
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Lexington VA Healthcare System, Lexington
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- University of Kentucky/Markey Cancer Center, Lexington
Pathways, a Hope Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life During Advanced Lung Cancer Treatment
În curs de recrutare
- University of Kentucky, Lexington
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- University of Kentucky/Markey Cancer Center, Lexington
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2/3
- University of Kentucky/Markey Cancer Center, Lexington
Precision Lung Cancer Survivorship Care Intervention
În curs de recrutare
- Markey Cancer Center, Lexington
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
În curs de recrutareFaza 1
- University of Kentucky Markey Cancer Center, Lexington
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Baptist Lexington, Lexington
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
În curs de recrutareStudiu observațional
- Lexington VA Health Care System, Lexington
Studii pentru Cancer pulmonar în alte orașe
- Houston, TX78 studii
- Boston, MA62 studii
- New York City, NY60 studii
- Los Angeles, CA45 studii
- Washington, DC41 studii
- Arlington, VA41 studii
- Chicago, IL41 studii
- Nashville, TN40 studii
- Baltimore, MD40 studii
- St. Louis, MO39 studii
- Columbus, OH37 studii
- Philadelphia, PA36 studii
Alte studii în Lexington
- Cancer pulmonar cu celule non-pătrate23 studii
- Cancer ovarian16 studii
- Cancer (toate tipurile)14 studii
- Cancer de prostată14 studii
- Cancer de sân14 studii
- Cancer metastatic11 studii
- Insuficiență cardiacă11 studii
- Cancer colorectal11 studii
- Obezitate10 studii
- Leucemie mieloasă acută10 studii
- Melanom10 studii
- Cancer pancreatic9 studii
Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.